Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

miR-494-3p is a novel tumor driver of lung carcinogenesis.

Faversani A, Amatori S, Augello C, Colombo F, Porretti L, Fanelli M, Ferrero S, Palleschi A, Pelicci PG, Belloni E, Ercoli G, Degrassi A, Baccarin M, Altieri DC, Vaira V, Bosari S.

Oncotarget. 2017 Jan 31;8(5):7231-7247. doi: 10.18632/oncotarget.13933.

2.

Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.

Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, Ballinari D, Ciomei M, Texido G, Degrassi A, Avanzi N, Amboldi N, Saccardo MB, Casero D, Orsini P, Bandiera T, Mologni L, Anderson D, Wei G, Harris J, Vernier JM, Li G, Felder E, Donati D, Isacchi A, Pesenti E, Magnaghi P, Galvani A.

Mol Cancer Ther. 2016 Apr;15(4):628-39. doi: 10.1158/1535-7163.MCT-15-0758. Epub 2016 Mar 3.

3.

Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.

Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M.

PLoS One. 2016 Mar 2;11(3):e0151008. doi: 10.1371/journal.pone.0151008. eCollection 2016. No abstract available.

4.

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.

Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M.

PLoS One. 2016 Jan 21;11(1):e0146622. doi: 10.1371/journal.pone.0146622. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151008. Texido, Gemma [added]; Degrassi, Anna [added].

5.

Exogenous adult postmortem neural precursors attenuate secondary degeneration and promote myelin sparing and functional recovery following experimental spinal cord injury.

Carelli S, Giallongo T, Marfia G, Merli D, Ottobrini L, Degrassi A, Basso MD, Di Giulio AM, Gorio A.

Cell Transplant. 2015;24(4):703-19. doi: 10.3727/096368914X685140. Epub 2014 Oct 8.

6.

Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.

Lo Dico A, Valtorta S, Martelli C, Belloli S, Gianelli U, Tosi D, Bosari S, Degrassi A, Russo M, Raccagni I, Lucignani G, Moresco RM, Ottobrini L.

Mol Imaging Biol. 2014 Apr;16(2):210-23. doi: 10.1007/s11307-013-0669-0.

PMID:
24002614
7.

NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases.

Fogliatto G, Gianellini L, Brasca MG, Casale E, Ballinari D, Ciomei M, Degrassi A, De Ponti A, Germani M, Guanci M, Paolucci M, Polucci P, Russo M, Sola F, Valsasina B, Visco C, Zuccotto F, Donati D, Felder E, Pesenti E, Galvani A, Mantegani S, Isacchi A.

Clin Cancer Res. 2013 Jul 1;19(13):3520-32. doi: 10.1158/1078-0432.CCR-12-3512. Epub 2013 May 14.

8.

Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.

Albanese C, Alzani R, Amboldi N, Degrassi A, Festuccia C, Fiorentini F, Gravina G, Mercurio C, Pastori W, Brasca M, Pesenti E, Galvani A, Ciomei M.

Br J Pharmacol. 2013 May;169(1):156-66. doi: 10.1111/bph.12112.

9.

In vivo imaging of lymph node migration of MNP- and (111)In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras).

Martelli C, Borelli M, Ottobrini L, Rainone V, Degrassi A, Russo M, Gianelli U, Bosari S, Fiorini C, Trabattoni D, Clerici M, Lucignani G.

Mol Imaging Biol. 2012 Apr;14(2):183-96. doi: 10.1007/s11307-011-0496-0.

PMID:
21598093
10.

Early versus late GD-DTPA MRI enhancement in experimental glioblastomas.

Farace P, Tambalo S, Fiorini S, Merigo F, Daducci A, Nicolato E, Conti G, Degrassi A, Sbarbati A, Marzola P.

J Magn Reson Imaging. 2011 Mar;33(3):550-6. doi: 10.1002/jmri.22472.

PMID:
21563238
11.

Labeling protocols for in vivo tracking of human skeletal muscle cells (HSkMCs) by magnetic resonance and bioluminescence imaging.

Libani IV, Lucignani G, Gianelli U, Degrassi A, Russo M, Bosari S, Clerici M, Ottobrini L.

Mol Imaging Biol. 2012 Feb;14(1):47-59. doi: 10.1007/s11307-011-0474-6.

PMID:
21336878
12.

Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.

Degrassi A, Russo M, Nanni C, Patton V, Alzani R, Giusti AM, Fanti S, Ciomei M, Pesenti E, Texido G.

Mol Cancer Ther. 2010 Mar;9(3):673-81. doi: 10.1158/1535-7163.MCT-09-0726. Epub 2010 Mar 2.

13.

Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.

Radaelli E, Ceruti R, Patton V, Russo M, Degrassi A, Croci V, Caprera F, Stortini G, Scanziani E, Pesenti E, Alzani R.

Histol Histopathol. 2009 Jul;24(7):879-91. doi: 10.14670/HH-24.879.

14.

DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.

Farace P, Merigo F, Fiorini S, Nicolato E, Tambalo S, Daducci A, Degrassi A, Sbarbati A, Rubello D, Marzola P.

Eur J Radiol. 2011 Apr;78(1):52-9. doi: 10.1016/j.ejrad.2009.04.043. Epub 2009 May 13.

PMID:
19443159
15.

Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas.

Farace P, Galiè M, Merigo F, Daducci A, Calderan L, Nicolato E, Degrassi A, Pesenti E, Sbarbati A, Marzola P.

Br J Cancer. 2009 May 19;100(10):1575-80. doi: 10.1038/sj.bjc.6605041. Epub 2009 Apr 21.

16.

Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.

Farace P, D'Ambrosio D, Merigo F, Galiè M, Nanni C, Spinelli A, Fanti S, Degrassi A, Sbarbati A, Rubello D, Marzola P.

Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):616-23. doi: 10.1007/s00259-008-1012-x. Epub 2008 Dec 18.

PMID:
19093111
17.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.

Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D, Moll J.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3158-68.

18.

A new oxygenator change-out system and procedure.

Da Broi U, Adami V, Falasca E, Malangone W, Crini S, Degrassi A.

Perfusion. 2006 Dec;21(5):297-303.

PMID:
17201085
19.

Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials.

Degrassi A, Russo M, Scanziani E, Giusti A, Ceruti R, Texido G, Pesenti E.

Prostate. 2007 Mar 1;67(4):396-404.

PMID:
17187397
20.

Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.

Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, Sbarbati A, Osculati F.

Clin Cancer Res. 2005 Aug 15;11(16):5827-32.

21.

A closed system for the clinical banking of umbilical cord blood.

Adami V, Malangone W, Falasca E, Marini L, Risso A, Crini S, Toniutti E, Passoni Ferraro E, Del Frate G, Pittino M, Biffoni F, Rinaldi C, Degrassi A.

Blood Cells Mol Dis. 2005 Nov-Dec;35(3):389-97. Epub 2005 Aug 19.

PMID:
16112591
22.

Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System".

Astori G, Adami V, Mambrini G, Bigi L, Cilli M, Facchini A, Falasca E, Malangone W, Panzani I, Degrassi A.

Bone Marrow Transplant. 2005 Jun;35(11):1101-6.

PMID:
15821764
23.

Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples.

Adami V, Falasca E, Dorotea L, Malangone W, Astori G, Marini L, Biffoni F, Rinaldi C, Degrassi A, Pipan C.

Clin Microbiol Infect. 2004 Dec;10(12):1075-80.

24.

In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model.

Marzola P, Degrassi A, Calderan L, Farace P, Crescimanno C, Nicolato E, Giusti A, Pesenti E, Terron A, Sbarbati A, Abrams T, Murray L, Osculati F.

Clin Cancer Res. 2004 Jan 15;10(2):739-50.

25.

In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure.

Marzola P, Farace P, Calderan L, Crescimanno C, Lunati E, Nicolato E, Benati D, Degrassi A, Terron A, Klapwijk J, Pesenti E, Sbarbati A, Osculati F.

Int J Cancer. 2003 Apr 20;104(4):462-8.

26.

Corticotropin-releasing factor, urocortin and endothelin-1 stimulate activin A release from cultured human placental cells.

Reis FM, Luisi S, Florio P, Degrassi A, Petraglia F.

Placenta. 2002 Jul;23(6):522-5.

PMID:
12137751
27.

A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.

Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E, Marini L, Spizzo R, Bigi L, Sala P, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, Pittino M, Degrassi A.

Blood Cells Mol Dis. 2001 Jul-Aug;27(4):715-24; discussion 725-7.

PMID:
11778655
28.

In vitro functional assessment of a porcine hepatocytes based bioartificial liver.

Donini A, Baccarani U, Risaliti A, Sanna A, Degrassi A, Bresadola F.

Transplant Proc. 2001 Nov-Dec;33(7-8):3477-9. No abstract available.

PMID:
11750488
29.

Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation.

Donini A, Baccarani U, Lavaroni S, Dialti V, Adami V, Risaliti A, Cautero N, Degrassi A, Bresadola F.

Transplant Proc. 2001 Feb-Mar;33(1-2):1972-3. No abstract available.

PMID:
11267592
30.

Porcine endogenous retrovirus does not infect human cells using a bioartificial liver model system.

Falasca E, Adami V, Astori G, Donini A, Biffoni F, Degrassi A, Botta GA, Pipan C.

Transplant Proc. 2001 Feb-Mar;33(1-2):1780-1. No abstract available.

PMID:
11267509
31.

Increased content of CD34(+)CD38(-) hematopoietic stem cells in the last collected umbilical cord blood.

Malangone W, Belvedere O, Astori G, Adami V, Donini A, Falasca E, Sala PG, Del Frate G, Pittino M, De Anna D, Degrassi A.

Transplant Proc. 2001 Feb-Mar;33(1-2):1766-8. No abstract available.

PMID:
11267504
32.

Flow cytometric characterization of ex vivo expanded umbilical cord blood CD34(+) cells.

Malangone W, Belvedere O, Feruglio C, Spizzo R, Astori G, Adami V, Dorotea L, Falasca E, Sala PG, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, De Anna D, Degrassi A.

Transplant Proc. 2001 Feb-Mar;33(1-2):1764-5. No abstract available.

PMID:
11267503
33.

Steatotic versus cirrhotic livers as a source for human hepatocyte isolation.

Baccarani U, Donini A, Risaliti A, Piccolo G, Dialti V, Cautero N, Degrassi A, Sirchia G, Bresadola F.

Transplant Proc. 2001 Feb-Mar;33(1-2):664-5. No abstract available.

PMID:
11267006
34.

Hepatocyte isolation using human livers discarded from transplantation: analysis of cell yield and function.

Donini A, Baccarani U, Piccolo G, Lavaroni S, Dialti V, Cautero N, Risaliti A, Degrassi A, Scalamogna M, Bresadola F.

Transplant Proc. 2001 Feb-Mar;33(1-2):654-5. No abstract available.

PMID:
11267001
35.

Efficiency of doxorubicin handling by isolated hepatocytes is a valuable indicator for restored cell function.

Crivellato E, Donini A, Baccarani U, Lavaroni S, Candussio L, Degrassi A, Bresadola F.

Histochem J. 2000 Sep;32(9):535-43.

PMID:
11127974
36.

Increased blood volume and CD34(+)CD38(-) progenitor cell recovery using a novel umbilical cord blood collection system.

Belvedere O, Feruglio C, Malangone W, Bonora ML, Minisini AM, Spizzo R, Donini A, Sala P, De Anna D, Hilbert DM, Degrassi A.

Stem Cells. 2000;18(4):245-51.

37.

Is PERV transfer across hollow fiber membranes relevant to bioartificial liver model?

Falasca E, Baccarani U, Pipan C, Degrassi A, Donini A.

Transplantation. 2000 Apr 27;69(8):1755. No abstract available.

PMID:
10836401
38.

Temporary neurological improvement in a patient with acute or chronic liver failure treated with a bioartificial liver device.

Donini A, Baccarani U, Risaliti A, Degrassi A, Bresadola F.

Am J Gastroenterol. 2000 Apr;95(4):1102-4. No abstract available.

PMID:
10763984
39.

Phenotypic characterization of immunomagnetically purified umbilical cord blood CD34+ cells.

Belvedere O, Feruglio C, Malangone W, Bonora ML, Donini A, Dorotea L, Tonutti E, Rinaldi C, Pittino M, Baccarani M, Del Frate G, Biffoni F, Sala P, Hilbert DM, Degrassi A.

Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):141-6.

PMID:
10575539
40.

Cell cycle synchronization of FRTL5 cells. A physiological model system.

Degrassi A, Monaco MC, Lisignoli G, Belvedere O, Toneguzzi S, Malangone W, Bonora ML, Piacentini A, Lavaroni S, Scarbolo M, Ambesi-Impiombato FS, Facchini A.

J Exp Clin Cancer Res. 1998 Dec;17(4):527-32.

PMID:
10089079
41.

Bioartificial liver based on porcine hepatocyte: in vitro functional assessment.

Corno V, Donini A, Vianello V, Gonano C, Bonfreschi V, Pasqualotto A, Risaliti A, Belvedere O, Degrassi A, Bresadola F.

Transplant Proc. 1998 Aug;30(5):2469-70. No abstract available.

PMID:
9723542
42.

Ex vivo preparation of porcine hepatocytes for use in bioartificial hepatic support systems.

Donini A, Corno V, Lavaroni S, Pellerito R, Bigi L, Pasqualotto A, Belvedere O, Crivellato E, Degrassi A, Bresadola F.

Transplant Proc. 1997 Jun;29(4):1948-9. No abstract available.

PMID:
9193465
43.

A fluorescent in situ hybridization method in flow cytometry to detect HIV-1 specific RNA.

Borzì RM, Piacentini A, Monaco MC, Lisignoli G, Degrassi A, Cattini L, Santi S, Facchini A.

J Immunol Methods. 1996 Jun 21;193(2):167-76.

PMID:
8699030
44.

A method for generating magnetic resonance microimaging T2 maps with low sensitivity to diffusion.

Mlynárik V, Degrassi A, Toffanin R, Jarh O, Vittur F.

Magn Reson Med. 1996 Mar;35(3):423-5.

PMID:
8699955
45.

Investigation of laminar appearance of articular cartilage by means of magnetic resonance microscopy.

Mlynárik V, Degrassi A, Toffanin R, Vittur F, Cova M, Pozzi-Mucelli RS.

Magn Reson Imaging. 1996;14(4):435-42.

PMID:
8782182
46.

In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation.

Lisignoli G, Monaco MC, Facchini A, Toneguzzi S, Cattini L, Hilbert DM, Lavaroni S, Belvedere O, Degrassi A.

Eur J Immunol. 1996 Jan;26(1):17-27.

PMID:
8566062
47.

Effect of marrow processing on hematopoietic cell recovery in bone marrow harvests: focus on filtration.

Feruglio C, Savignano C, Silvestri F, Rinaldi C, Lavaroni S, Venturelli F, Degrassi A, Fanin R, Sala PG, Biffoni F, et al.

Bone Marrow Transplant. 1995 Dec;16(6):835-8.

PMID:
8750278
48.

Osteoblastic cell lines are not susceptible to HIV-1 infection.

Toneguzzi S, Lisignoli G, Monaco MC, Pozzi C, Bertollini V, Belvedere O, Degrassi A, Facchini A.

Boll Soc Ital Biol Sper. 1995 Sep-Oct;71(9-10):275-9.

PMID:
8962698
49.

Effect of stromal cells from human lymph nodes on the growth of osteosarcoma cell lines.

Lisignoli G, Toneguzzi S, Monaco MC, Tomassetti M, Bertollini V, Lavaroni S, Degrassi A, Facchini A.

Boll Soc Ital Biol Sper. 1995 Sep-Oct;71(9-10):263-7.

PMID:
8962696
50.

Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives, and on the metabolism of articular chondrocytes.

Kvam BJ, Fragonas E, Degrassi A, Kvam C, Matulova M, Pollesello P, Zanetti F, Vittur F.

Exp Cell Res. 1995 May;218(1):79-86.

PMID:
7737382

Supplemental Content

Loading ...
Support Center